Trials / Completed
CompletedNCT03658343
T2* MRI Analysis for Sarcoma
An Exploratory, Pilot Study Evaluating T2* Imaging for Adult Sarcoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (actual)
- Sponsor
- Bryan Allen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
T2\* imaging is a method to identify labile iron pools in tumor cells. These iron pools may be linked to better treatment outcomes for specific types of therapy. This is a small pilot study to see if radiation therapy changes the amount of iron in a sarcoma tumor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | T2* Imaging | T2\* imaging sequences for MRI |
Timeline
- Start date
- 2018-09-18
- Primary completion
- 2022-02-25
- Completion
- 2022-02-25
- First posted
- 2018-09-05
- Last updated
- 2025-02-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03658343. Inclusion in this directory is not an endorsement.